PubMed COVID-19 Clinical Care
16331 - 16340 of 44979 results found
"It's Like Being a Parent at Work": Antiviolence Frontline Work, Boundaries, and Intimacy During COVID-19
Description
COVID-19 profoundly shaped how service providers in the antiviolence sector interact with clients, coworkers, and community stakeholders. In addition to stressors inherent in antiviolence work, service providers negotiated new, challenging social
Case Report: Branch Retinal Vein Occlusion Post mRNA SARS-CoV-2 (COVID-19) Vaccination
Description
CONCLUSIONS: This case illustrates a clear temporal and possible causal relationship between COVID-19 vaccination and retinal vein occlusion. Post vaccination transient hypertension, or the immunological and inflammatory response to the vaccine may
The potential role of ferroptosis in COVID-19-related cardiovascular injury
Description
COVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged as a global health threat in 2019. An important feature of the disease is that multiorgan symptoms of SARS-CoV-2 infection persist after recovery. Evidence
Effectiveness of Monovalent mRNA Vaccines Against Omicron XBB Infection in Singaporean Children Younger Than 5 Years
Description
CONCLUSIONS AND RELEVANCE: Study results suggest that completion of a primary mRNA vaccine series provided protection against SARS-CoV-2 infection in children aged 1 through 4 years. Although incidence of hospitalization and severe illness is low in
Possible mechanism of central nervous system targeting and neurological symptoms of the new-coronavirus (COVID-19): literature review
Description
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that caused the 2019 Coronavirus Disease (COVID-19) has been associated with several neurological symptoms. This review aimed to highlight the possible mechanism of central nervous
First detection of SARS-CoV-2 BA.2.86.1 in Italy
Description
No abstract
Main Aspects of Pharmaceutical Development of In situ Immunobiological Drugs for Intranasal Administration
Description
INTRODUCTION: The review presents the latest developments in the area of intranasal in situ delivery systems of immunobiological drugs (IBDs). Interest in intranasal administration for IBDs has increased significantly due to the COVID-19 pandemic
